Colt CZ Group SE
Colt CZ Group SE (CZGZF) Financial Performance & Income Statement Overview
Analyze Colt CZ Group SE (CZGZF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Colt CZ Group SE (CZGZF) Income Statement & Financial Overview
View the income breakdown for Colt CZ Group SE CZGZF across both annual and quarterly reports.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $7.58B | $5.04B | $6.02B | $3.72B |
Cost of Revenue | $5.04B | $3.08B | $5.29B | $2.38B |
Gross Profit | $2.54B | $1.96B | $737.53M | $1.34B |
Gross Profit Ratio | $0.33 | $0.39 | $0.12 | $0.36 |
R&D Expenses | $20.43M | $6.88M | $6.81M | $6.74M |
SG&A Expenses | $1.14B | $1.09B | $5.30M | $896.01M |
Operating Expenses | $1.78B | $1.62B | $12.11M | $1.007B |
Total Costs & Expenses | $6.82B | $4.69B | $5.30B | $3.38B |
Interest Income | $0.00 | $0.00 | $47.33M | $41.47M |
Interest Expense | $0.00 | $0.00 | $322.13M | $0.00 |
Depreciation & Amortization | $529.24M | $424.34M | $354.12M | $181.57M |
EBITDA | $1.29B | $765.63M | $1.10B | $812.76M |
EBITDA Ratio | $0.17 | $0.15 | $0.18 | $0.22 |
Operating Income | $760.00M | $342.25M | $725.42M | $220.82M |
Operating Income Ratio | $0.10 | $0.07 | $0.12 | $0.06 |
Other Income/Expenses (Net) | -$301.02M | -$216.17M | -$305.53M | $153.16M |
Income Before Tax | $458.97M | $126.08M | $419.89M | $374.62M |
Income Before Tax Ratio | $0.06 | $0.03 | $0.07 | $0.10 |
Income Tax Expense | $123.06M | $27.04M | $113.81M | $71.36M |
Net Income | $335.92M | $99.04M | $306.36M | $303.26M |
Net Income Ratio | $0.04 | $0.02 | $0.05 | $0.08 |
EPS | $5.77 | $1.90 | $6.08 | $8.33 |
Diluted EPS | $6.00 | $1.88 | $6.08 | $6.00 |
Weighted Avg Shares Outstanding | $58.17M | $52.01M | $50.37M | $50.54M |
Weighted Avg Shares Outstanding (Diluted) | $55.96M | $52.59M | $50.37M | $49.88M |
Over the last four quarters, Colt CZ Group SE achieved steady financial progress, growing revenue from $3.72B in Q1 2024 to $7.58B in Q4 2024. Gross profit stayed firm with margins at 33% in Q4 2024 versus 36% in Q1 2024. Operating income totaled $760.00M in Q4 2024, maintaining a 10% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.29B. Net income rose to $335.92M, with EPS at $5.77. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan